Yasuhiro Takikawa

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 254 citations · Full text

The Bile Acid Glycochenodeoxycholate Induces TRAIL-Receptor 2/DR5 Expression and Apoptosis

Hajime Higuchi, Steven F. Bronk, Yasuhiro Takikawa et al. · Journal of Biological Chemistry · 2001 · 186 citations · Full text

The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease

Yudai Fujiwara, Hidekatsu Kuroda, Tamami Abe et al. · Ultrasound in Medicine & Biology · 2018 · 151 citations

Medical Ultrasound, Hepatology, Medical Imaging +12

Diagnostic criteria of acute liver failure: A report by the Intractable Hepato‐Biliary Diseases Study Group of Japan

Satoshi Mochida, Yasuhiro Takikawa, Nobuaki Nakayama et al. · Hepatology Research · 2011 · 150 citations

Diagnosis, Pathology, Gastroenterology +21

FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration

Hinako M. Takase, Tohru Itoh, Seitaro Ino et al. · Genes & Development · 2013 · 138 citations · Full text

Lpc Activation, Immunology, Cell Death +23